Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

There is increasing interest in the potential functional role of the octapeptide angiotensin II (AII) in psychiatric and cognitive disorders. The novel angiotensin II (AII) receptor antagonists, losartan and PD123177, selective for the AT1 and AT2 receptor subtypes respectively, constitute important pharmacological tools for the assessment of the behavioural consequences of modulation of AII function. The present series of studies investigated the effects of each compound in two animal models of anxiety, the rat elevated zero-maze and mouse light/dark box, and two models of working memory in the rat, the operant delayed matching to position (DMTP) task and the spatial reinforced alternation test in the T-maze. Our data indicate that both compounds (0.01-10 mg/kg s.c.) were without significant effect in any of the behavioural assays. Using the present methods and strains of laboratory rodents, these findings provide no support for the involvement of AII receptor function in the mediation of anxiety of working memory.

Type

Journal article

Journal

Psychopharmacology (Berl)

Publication Date

08/1996

Volume

126

Pages

206 - 218

Keywords

Angiotensin II, Angiotensin Receptor Antagonists, Animals, Anti-Anxiety Agents, Anxiety, Biphenyl Compounds, Diazepam, Dose-Response Relationship, Drug, Imidazoles, Losartan, Male, Memory, Motor Activity, Pyridines, Rats, Rats, Sprague-Dawley, Scopolamine Hydrobromide, Tetrazoles